Archive \ Volume.13 2022 Issue 2

Infection Control in Dental Practice During COVID-19 Pandemic: A Literature Review

Amani Naser Almofareh, Bdour Boreaesh Alenazi, Kholoud Saud Ali Alanizy, Munirah Fatis Alshahrani, Ahad Hussain Alharbi, Sumayah Atiq Allah Al-Mutairi, Afnan Hussain Alharbi, Norah Falah Alnawmasi, Ghadah Fayaz Bin Jasar, Abdulaziz Mohammed Alamri, Dhafer Mohammed Alshehri

COVID-19 causes severe pneumonia, which is aided by the SARS-CoV-2 virus. The pathophysiology of the COVID-19 sickness, the unusual transmissibility of SARS-CoV-2, and our age's high level of globalization have all led to the rapid global spread of China's epidemic emergency. For COVID-19 to spread from person to person, it just takes intimate contact with an infected individual. The virus is spread mainly through the inhalation of respiratory droplets, which may be applied when a person with the infection talks, sneezes, or coughs. It is also known that the virus may live in the environment, either in the air or on inanimate objects (known as "fomites"). Dentists are at a higher risk of developing SARS-CoV-2 because they frequently interact closely with patients and are exposed to human fluids such as saliva, blood, and tissue during surgical procedures. Many dental operations emit aerosol, and the possibility of an airborne infection should be recognized. This study seeks to give dentists useful guidelines based on current research that may assist them in preventing the spread of COVID-19 while working with patients.

Downloads: 46
Views: 102

How to cite:
Almofareh AN, Alenazi BB, Alanizy KSA, Alshahrani MF, Alharbi AH, Al-Mutairi SAA, et al. Infection Control in Dental Practice During COVID-19 Pandemic: A Literature Review. Arch Pharm Pract. 2022;13(2):116-22.
Almofareh, A. N., Alenazi, B. B., Alanizy, K. S. A., Alshahrani, M. F., Alharbi, A. H., Al-Mutairi, S. A. A., Alharbi, A. H., Alnawmasi, N. F., Jasar, G. F. B., Alamri, A. M., et al. (2022). Infection Control in Dental Practice During COVID-19 Pandemic: A Literature Review. Archives of Pharmacy Practice, 13(2), 116-122.

Download Citation

1.        WHO. Pneumonia of Unknown Cause—China; WHO: Geneva, Switzerland, 2020.

2.        Alghamdi A, Ibrahim A, Alraey M, Alkazemi A, Alghamdi I, Alwarafi G. Side effects following COVID-19 vaccination: A cross-sectional survey with age-related outcomes in Saudi Arabia. J Adv Pharm Educ Res. 2021;11(3):119-25.

3.        Bahramy MA, Roozdar-Chaleshtary M, Abbasi V, Amiri-Nikpour MR, Moradi-Joo E. Clinical Features of Guillain-Barre Syndrome in COVID-19 Patients: Aria and Naft Private Hospitals in Ahvaz, Iran. Entomol Appl Sci Lett. 2021;(3):21-7.

4.        Magomedova UG, Khadartseva ZA, Grechko VV, Polivanova MN, Mishvelov AE, Povetkin SN, et al. The role of Covid-19 in the acute respiratory pathology formation in children. Pharmacophore. 2020;11(5):61-5.

5.        Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369.

6.        Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172(9):577-82.

7.        Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic Transmission of SARS-CoV-2—Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411-5.

8.        Johns Hopkins University & Medicine. Coronavirus Resource Center: COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at John Hopkins. 2020. Available from: (accessed on 2 March 2021).

9.        CDC. How COVID-19 Spreads. CDC’s Website. 2020. Available from: (accessed on 2 March 2021).

10.      NHC. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia; National Health Commission of the PRC: Beijing, China, 2020.

11.      Harrel SK, Molinari J. Aerosols and splatter in dentistry: A brief review of the literature and infection control implications. J Am Dent Assoc. 2004;135(4):429-37.

12.      Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.

13.      Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-23.

14.      Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6.

15.      Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group. BioRxiv. 2020.

16.      Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. eLife. 2020;9:e55570.

17.      Li P, Fu JB, Li KF, Liu JN, Wang HL, Liu LJ, et al. Transmission of COVID-19 in the terminal stages of the incubation period: A familial cluster. Int J Infect Dis. 2020;96:452-3.

18.      Li C, Ji F, Wang L, Wang L, Hao J, Dai M, et al. Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster, Xuzhou, China. Emerg Infect Dis. 2020;26(7):1626-8.

19.      Lavezzo E, Franchin E, Ciavarella C, Cuomo-Dannenburg G, Barzon L, Del Vecchio C, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584(7821):425-9.

20.      Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci USA. 2020;117(30):17513-5.

21.      Burki TK. Coronavirus in China. Lancet Respir Med. 2020;8(3):238.

22.      Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

23.      Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;26(6):1320.

24.      Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2020.

25.      Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39.

26.      Lee YL, Chu D, Chou SY, Hu HY, Huang SJ, Yen YF. Dental care and infection-control procedures during the COVID-19 pandemic: The experience in Taipei City Hospital, Taiwan. J Dent Sci. 2020;15(3):369-72.

27.      Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, et al. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020;151(11):815-24.

28.      Patel M. Infection control in dentistry during COVID–19 pandemic: what has changed? Heliyon. 2020;6(10):e05402.

29.      Pereira LJ, Murata RM, Pardi V, Mattos FF. Streamlining the dental care during COVID-19 pandemic: updated clinical recommendations and infection control management framework. Braz Oral Res. 2021;35:e046.

30.      Induri SNR, Chun YC, Chun JC, Fleisher KE, Glickman RS, Xu F, et al. Protective Measures against COVID-19: Dental Practice and Infection Control. Healthcare (Basel). 2021;9(6):679. doi:10.3390/healthcare9060679

31.      Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM. Coronavirus disease 19 (COVID-19): implications for clinical dental care. J Endod. 2020;46(5):584-95.

32.      Ayyed AB. Dental practice infection control measurements: Coronavirus Disease (COVID-19) Outbreaks. Int J Clin Pediatr Dentist. 2020;13(3):279.

33.      Kochhar AS, Bhasin R, Kochhar GK, Dadlani H. COVID-19 pandemic and dental practice. Int J Dent. 2020;2020.

34.      WHO. Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID-19; WHO: Geneva, Switzerland, 2020.

35.      PHAC. Infection Prevention and Control for COVID-19: Interim Guidance for Outpatient and Ambulatory Care Settings; Public Health Agency of Canada: Ottawa, ON, Canada, 2020.

36.      Pittet D, Allegranzi B, Boyce J. World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts. The World Health Organization Guidelines on Hand Hygiene in Health Care and Their Consensus Recommendations. Infect Control Hosp Epidemiol. 2009;30(7):611-22.

37.      Gold NA, Avva U. Alcohol Sanitizer. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2020.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.